KYNTRA BIO, INC. (KYNB) Operating margin 2016–2025
KYNTRA BIO, INC. (KYNB) operating margin by fiscal year — reported operating income divided by reported revenue.
-712.7%FY2025 · since FY2016: -27.3% → -712.7%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -712.7% | -204.9 pp |
| FY2024 | -507.8% | +181.7 pp |
| FY2023 | -689.5% | -475.6 pp |
| FY2022 | -213.9% | -91.3 pp |
| FY2021 | -122.6% | -13.8 pp |
| FY2020 | -108.8% | -74.0 pp |
| FY2019 | -34.8% | +5.9 pp |
| FY2018 | -40.7% | +48.8 pp |
| FY2017 | -89.5% | -62.2 pp |
| FY2016 | -27.3% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice